Norman Molyneux

Chief Executive Officer at

Acceleris Corporate Ventures Ltd.

70 year

18 connections

Finance

Commercial Services

Health Technology

Profile

Norman Molyneux is the founder of Acceleris Capital Ltd. (founded in 2000) where he held the title of Chief Executive Officer.
He was also the founder of Redx Pharma Plc (founded in 2010) where he held the title of Non-Executive Director from 2014 to 2017.
Currently, he is the Chief Executive Officer at Acceleris Corporate Ventures Ltd. since 2002.
He is also a Non-Executive Director at Reacta Biotech Ltd. and a Member of ESI Association.
Previously, he held the position of Director at BiVictriX Therapeutics Plc from 2018 to 2021 and worked as a Management Consultant at PricewaterhouseCoopers LLP.
He also held the position of Principal at Seneca Partners Ltd. Mr. Molyneux is also the founder of Redag Crop Protection Ltd.

Norman Molyneux active positions

Companies	Position	Start
Acceleris Corporate Ventures Ltd. Acceleris Corporate Ventures Ltd. Investment ManagersFinance Provides consulting services to early stage companies	Chief Executive Officer	01/01/2002
ESI Association ESI Association ESI Association is a non-profit company based in London, UK.	Corporate Officer/Principal	28/06/2011
Reacta Biotech Ltd. Reacta Biotech Ltd. Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and supplies oral food materials and technologies to pharmaceuticals	Director/Board Member	-

All active positions of Norman Molyneux

Former positions of Norman Molyneux

Companies	Position	End
BIVICTRIX THERAPEUTICS PLC	Director/Board Member	11/08/2021
REDX PHARMA LTD	Founder	06/11/2017
Seneca Partners Ltd. Seneca Partners Ltd. Investment ManagersFinance Seneca Partners invests in SME companies located in UK. The firm is a sector-agnostic and provides financing in the form of equity and debt for growth ambitions, IPOs, management buy outs/buy-ins, retirement sales and corporate acquisition strategies in the range of GBP 0.5-3 million per transaction. It also acts as sole or lead investor or in combination with external co-investment parties.	Private Equity Investor	-
Redag Crop Protection Ltd. Redag Crop Protection Ltd. Chemicals: AgriculturalProcess Industries Produces agro-chemicals, fungicides, herbicides, insecticides and nematicides	Founder	-
Acceleris Capital Ltd. Acceleris Capital Ltd. Investment ManagersFinance Provides corporate finance advice and raises funds for early and development stage businesses	Chief Executive Officer	-

See the detail of Norman Molyneux's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Norman Molyneux's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
PricewaterhouseCoopers LLP PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services	Commercial Services
Acceleris Corporate Ventures Ltd. Acceleris Corporate Ventures Ltd. Investment ManagersFinance Provides consulting services to early stage companies	Finance
Acceleris Capital Ltd. Acceleris Capital Ltd. Investment ManagersFinance Provides corporate finance advice and raises funds for early and development stage businesses	Finance
Redx Pharma Plc Redx Pharma Plc Pharmaceuticals: MajorHealth Technology Discovers and develops novel, small molecule & targeted therapeutics for treatment of cancer and fibrotic disease	Health Technology
ESI Association ESI Association ESI Association is a non-profit company based in London, UK.
Reacta Biotech Ltd. Reacta Biotech Ltd. Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and supplies oral food materials and technologies to pharmaceuticals	Commercial Services
Redag Crop Protection Ltd. Redag Crop Protection Ltd. Chemicals: AgriculturalProcess Industries Produces agro-chemicals, fungicides, herbicides, insecticides and nematicides	Process Industries
Seneca Partners Ltd. Seneca Partners Ltd. Investment ManagersFinance Seneca Partners invests in SME companies located in UK. The firm is a sector-agnostic and provides financing in the form of equity and debt for growth ambitions, IPOs, management buy outs/buy-ins, retirement sales and corporate acquisition strategies in the range of GBP 0.5-3 million per transaction. It also acts as sole or lead investor or in combination with external co-investment parties.	Finance
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and distributes cancer therapeutics	Health Technology